Why the study?
To assess cardiac function using 2D-STI in patients with diabetic nephropathy and investigate the relationship between albuminuria and early cardiac systolic and diastolic dysfunction, along with associated clinical risk factors.
Does two-dimensional speckle-tracking echocardiography detect a higher prevalence of subclinical left ventricular systolic dysfunction in patients with diabetic nephropathy compared to those with diabetes mellitus alone?
Does two-dimensional speckle-tracking echocardiography detect a higher prevalence of subclinical left ventricular systolic dysfunction in patients with diabetic nephropathy compared to those with diabetes mellitus alone?
Two-dimensional speckle-tracking echocardiography reveals that patients with diabetic nephropathy have a significantly higher prevalence of subclinical left ventricular systolic dysfunction compared to those with diabetes alone, with total cholesterol identified as an independent risk factor.
Objective To assess cardiac function using two-dimensional speckle-tracking echocardiography (2D-STI) in diabetic nephropathy (DN) patients and investigate the relationship between albuminuria and early cardiac systolic and diastolic dysfunction, along with associated risk factors based on clinical indicators. Methods A total of 75 patients with DN, 100 patients with diabetes mellitus (DM), and 37 healthy controls were recruited. Clinical data were collected, and conventional echocardiography as well as 2D-STI were performed on all participants. Results 2D-STI findings revealed a significant increased occurrence rate of subclinical left ventricular systolic dysfunction [global longitudinal strain values (GLS) <18%], among diabetic patients compared to healthy controls. Furthermore, the proportion of GLS<18% occurrence was higher in the DN group compared to the DM group (p<0.001) and especially higher in the massive albuminuria group than that in the microalbuminuria group ( p <0.001). The results demonstrated that albuminuria, eGFR<60 ml/min/1.73 m 2 , and total cholesterol were identified as significant risk factors for the development of subclinical left ventricular systolic insufficiency in diabetic patients. However, when considering only patients with DN and adjusting for covariates, it was found that only total cholesterol remained statistically significant ( p < 0.05). Conclusion The higher cholesterol levels in patients with DN are associated with a greater risk of subclinical left ventricular systolic dysfunction reflected by a decrease in GLS assayed with 2D-STI. Critical relevance statement GLS measured by 2D-STI combined with clinical indexes to evaluate and predict subclinical left ventricular systolic function in patients with DM, providing reference for early prevention and treatment of cardiac dysfunction in patients with DN.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: